Over the past few years, cats have increasingly attracted media attention due to a number of scientific studies reporting that a Toxoplasma Gondii (T. Gondii) infection is linked with mental health issues, including schizophrenia, suicide and intermittent rage disorder. Since domestic cats are the primary hosts of T. Gondii – that is, they provide an environment within which this parasite can reproduce – it is often speculated that cat ownership may put people at increased risk of mental illness, by exposing them to it.
However, only a handful of small studies have found evidence to support a link between owning a cat and psychotic disorders, such as schizophrenia. And most of these investigations have serious limitations. For instance, they relied on small samples, did not specify how participants were selected, and did not appropriately account for the presence of missing data and alternative explanations. This can often lead to results that are born out of chance or are biased.
To tackle these limitations, we conducted a study using data from approximately 5,000 children who took part in the Avon Longitudinal Study of Parents and Children between 1991 and 1992. Since then, these children and their families have been followed up to gather information on their health, as well as on their demographic, social and economic circumstances.
So, unlike previous studies, we were able to follow people over time, from birth to late adolescence, and address a number of the limitations of previous research, including controlling for alternative explanations (such as income, occupation, ethnicity, other pet ownership and over-crowding) and taking into account missing data.
We studied whether mothers who owned a cat while pregnant; when the child was four years old; and 10 years old, were more likely to have children who reported psychotic symptoms, such as paranoia or hallucinations, at age 13 and 18 years of age. Although most people who experience psychotic symptoms in adolescence will not develop psychotic disorders later in life, these symptoms often indicate an increased risk for such disorders and other mental illnesses, including depression.
So are cats bad for your mental health? Probably, not.
We found that children who were born and raised in households that included cats at any time period – that is, pregnancy, early and late childhood – were not at a higher risk of having psychotic symptoms when they were 13 or 18 years old. This finding in a large, representative sample did not change when we used statistical techniques to account for missing data and alternative explanations. This means that it is unlikely that our results are explained by chance or are biased.
While this finding is reassuring, there is evidence linking exposure to T. Gondii in pregnancy to a risk of miscarriage and stillbirth, or health problems in the baby. In our study, we could not directly measure exposure to T. Gondii, so we recommend that pregnant women should continue to avoid handling soiled cat litter and other sources of T. Gondii infection, such as raw or undercooked meats, or unwashed fruit and vegetables. That said, data from our study suggests that owning a cat during pregnancy or in early childhood does not pose a direct risk for offspring having psychotic symptoms later in life.
James Kirkbride receives funding from the Wellcome Trust, the Royal Society, the Challenge and MHRUK.
Francesca Solmi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond the academic appointment above.


Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 



